A new Canadian real-world study, ACTIONS (chAracterizing oral Corticosteroid use in patients with chronic rhInOsinusitis with ...

For an estimated 30 million American adults, breathing can be a daily struggle. Now, there’s a potentially game-changing ...

The TikToker claimed that her bare-butted significant other at the time let out a particularly smelly fart that led chronic ...

National Institutes of Health grant will fund randomized clinical trial for treatments Timothy Smith, M.D., M.P.H., professor and ...

Lyra's LYR-210 met key goals in a Phase 3 trial for chronic rhinosinusitis, showing early and sustained symptom relief with a ...

The second indication is as an add-on maintenance treatment of adult patients with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP). The NDS is based on data from the ...

Lyra also reported success on key secondary endpoints. These included improvements in broader symptom scores and patient ...

The second indication is as an add-on maintenance treatment of adult patients with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP). The NDS is based on data from the positive ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Chronic frontal sinusitis is the term for the condition ... Other possible causes include allergies, a deviated nasal septum, and nasal polyps. Symptoms of frontal sinusitis may include nasal ...

Type 2 CRSwNP is linked to worse health-related quality of life, with higher rates of smell loss and rhinorrhea emerging as ...

Shares of Lyra Therapeutics, Inc. (LYRA) rocketed 370% on Monday after the company announced positive results from its ...